Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Minh Thu Nguyen
Affiliation
Institute of Medical Microbiology, University Hospital of Munster
ORCID
Career Start Year
1993
Papers
54
H Index
22
Expertise
CM4AI Collaborator
Vardit Ravitsky (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36262324
<i>Staphylococcus aureus</i> lipoproteins in infectious diseases.
Front Microbiol
2022
35402437
"The Stakes Are Higher"- Patient and Caregiver Perspectives on Cystic Fibrosis Research and Personalized Medicine.
Front Med (Lausanne)
2022
35356518
Lipoproteins Cause Bone Resorption in a Mouse Model of <i>Staphylococcus aureus</i> Septic Arthritis.
Front Microbiol
2022
34067090
The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada.
J Pers Med
2021
33785850
Staphylococcus aureus lipoproteins promote abscess formation in mice, shielding bacteria from immune killing.
Commun Biol
2021
33732047
Inhibition of biofilm formation by alpha-mangostin loaded nanoparticles against <i>Staphylococcus aureus</i>.
Saudi J Biol Sci
2021
31515903
Staphylococcus aureus Lpl protein triggers human host cell invasion via activation of Hsp90 receptor.
Cell Microbiol
2020
33448340
Elective surgery in asymptomatic patients with undetected SARS-CoV-2 infection: lessons learned from the global operating room.
Br J Surg
2020
33042100
Lipoproteins in Gram-Positive Bacteria: Abundance, Function, Fitness.
Front Microbiol
2020
32804063
Of the Rights and Best Interests of Future Generations.
Am J Bioeth
2020
32176433
Involvement of caspase-1 in inflammasomes activation and bacterial clearance in S. aureus-infected osteoblast-like MG-63 cells.
Cell Microbiol
2020
32404866
The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis.
Sci Rep
2020
30361155
Pre-implantation Genetic Diagnosis: The Road Forward in Canada.
J Obstet Gynaecol Can
2019
31226163
The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus.
PLoS Pathog
2019
31191485
Inactivation of <i>farR</i> Causes High Rhodomyrtone Resistance and Increased Pathogenicity in <i>Staphylococcus aureus</i>.
Front Microbiol
2019
31118484
Staphylococcus aureus induces DNA damage in host cell.
Sci Rep
2019
28733824
Diagnosis of rare diseases under focus: impacts for Canadian patients.
J Community Genet
2018
30209799
Autologous bilayered self-assembled skin substitutes (SASSs) as permanent grafts: a case series of 14 severely burned patients indicating clinical effectiveness.
Eur Cell Mater
2018
29844243
Toll-Like Receptor 2 and Lipoprotein-Like Lipoproteins Enhance Staphylococcus aureus Invasion in Epithelial Cells.
Infect Immun
2018
30361457
Erratum for Nguyen et al., "Toll-Like Receptor 2 and Lipoprotein-Like Lipoproteins Enhance Staphylococcus aureus Invasion in Epithelial Cells".
Infect Immun
2018
29595433
Research on Human Embryos and Reproductive Materials: Revisiting Canadian Law and Policy.
Healthc Policy
2018
29203111
Staphylococcal (phospho)lipases promote biofilm formation and host cell invasion.
Int J Med Microbiol
2018
29320746
SadA-Expressing Staphylococci in the Human Gut Show Increased Cell Adherence and Internalization.
Cell Rep
2018
29317198
Rhodomyrtone (Rom) is a membrane-active compound.
Biochim Biophys Acta Biomembr
2018
28901671
Aspartate tightens the anchoring of staphylococcal lipoproteins to the cytoplasmic membrane.
Microbiologyopen
2017
28110918
Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria.
Int J Antimicrob Agents
2017
28214849
Lipopeptide-Induced Suicidal Erythrocyte Death Correlates with the Degree of Acylation.
Cell Physiol Biochem
2017
29150485
Correction for Ebner et al., "Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus".
Infect Immun
2017
29269769
Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses.
Nat Commun
2017
28971248
Staphylococcus carnosus: from starter culture to protein engineering platform.
Appl Microbiol Biotechnol
2017
28542586
Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus.
PLoS Pathog
2017
27001537
Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus.
Infect Immun
2016
28083519
<i>Staphylococcus aureus</i> Lpl Lipoproteins Delay G2/M Phase Transition in HeLa Cells.
Front Cell Infect Microbiol
2016
27599532
Next-Generation Sequencing and the Return of Results.
Cold Spring Harb Perspect Med
2016
27679612
Evaluation of Staphylococcus aureus Lipoproteins: Role in Nutritional Acquisition and Pathogenicity.
Front Microbiol
2016
27512100
Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence.
Microbiol Mol Biol Rev
2016
27245927
Synthetically Tuning the 2-Position of Halogenated Quinolines: Optimizing Antibacterial and Biofilm Eradication Activities via Alkylation and Reductive Amination Pathways.
Chemistry
2016
27018907
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
J Med Chem
2016
25421945
The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice.
Clin Genet
2015
26406338
Correction: The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells.
PLoS Pathog
2015
26502910
Skin-Specific Unsaturated Fatty Acids Boost the Staphylococcus aureus Innate Immune Response.
Infect Immun
2015
25982664
A Phytochemical-Halogenated Quinoline Combination Therapy Strategy for the Treatment of Pathogenic Bacteria.
ChemMedChem
2015
24078715
Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
J Med Genet
2014
24906018
FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project.
Am J Hum Genet
2014
21226530
Structural, electronic, and theoretical description of a series of cobalt clathrochelate complexes in the Co(III), Co(II) and Co(I) oxidation states.
J Phys Chem A
2011
20219355
Enzymatic pretreatment of Chlamydomonas reinhardtii biomass for ethanol production.
Bioresour Technol
2010
19307765
Hydrothermal acid pretreatment of Chlamydomonas reinhardtii biomass for ethanol production.
J Microbiol Biotechnol
2009
15647759
Stored tissue samples: through the confidentiality maze.
Pharmacogenomics J
2005
8970703
Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans.
AIDS
1996
7662195
Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.
AIDS
1995
1 - 50 of 54
Column Actions
Search
Recommended Authors
Charles Ochieng' Olwal
University of Ghana
Career Start Year
2018
Number of shared co-authors
0
Md Zahidul Alam
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2014
Number of shared co-authors
0
Yogesh Hooda
Child Health Research Foundation
Career Start Year
2009
Number of shared co-authors
0
David J Gonzalez
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year
2008
Number of shared co-authors
0
Priyanka Priyanka
All India Institute of Medical Sciences
Career Start Year
2007
Number of shared co-authors
0
Scott D Pope
Yale School of Medicine, USA Howard Hughes Medical Institute
Career Start Year
2005
Number of shared co-authors
0
Ian McHardy
University of California, Davis Center for Valley Fever
Career Start Year
2005
Number of shared co-authors
0
Parham Sendi
Institute for Infectious Diseases, University of Bern
Career Start Year
2004
Number of shared co-authors
0
Mohammad Imran Khan
King Abdulaziz University (KAU), King Abdulaziz University
Career Start Year
2004
Number of shared co-authors
0
Megha Shah
University of Toronto, University Avenue
Career Start Year
2003
Number of shared co-authors
0
Sun-Hee Ahn
The Warren Alpert Medical School of Brown University/Rhode Island Hospital
Career Start Year
2002
Number of shared co-authors
0
Fernanda P Silveira
Federal University of Rio de Janeiro
Career Start Year
1998
Number of shared co-authors
0
Martin Fraunholz
Julius-Maximilians-Universitat Wurzburg
Career Start Year
1998
Number of shared co-authors
0
Alan M O'Neill
University of California San Diego
Career Start Year
1998
Number of shared co-authors
0
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year
1997
Number of shared co-authors
0
David M Aronoff
Indiana University School of Medicine
Career Start Year
1997
Number of shared co-authors
0
Rodrigo Andres Floto
University of Cambridge
Career Start Year
1995
Number of shared co-authors
0
Yolanda Gil
Hospital Universitario de Mostoles C/Dr. Luis Montes
Career Start Year
1995
Number of shared co-authors
0
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year
1995
Number of shared co-authors
0
Pierre-Yves Bochud
Lausanne University Hospital
Career Start Year
1994
Number of shared co-authors
0
Paul D Fey
University of Nebraska Medical Center
Career Start Year
1993
Number of shared co-authors
0
Victor Nizet
university of california san diego School of Medicine
Career Start Year
1991
Number of shared co-authors
0
Iftikhar Ahmed
International Islamic University
Career Start Year
1990
Number of shared co-authors
0
A M Joffe
University of Washington
Career Start Year
1988
Number of shared co-authors
0
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Career Start Year
1982
Number of shared co-authors
0
Michael S Gilmore
Harvard Medical School, USA Infectious Disease Institute (P.J.M.B.
Career Start Year
1981
Number of shared co-authors
0
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Career Start Year
1981
Number of shared co-authors
0
Robert E W Hancock
University of British Columbia
Career Start Year
1974
Number of shared co-authors
1
Uwe V??lker
University Medicine
Career Start Year
1974
Number of shared co-authors
2
David C Hooper
Massachusetts General Hospital
Career Start Year
1962
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Bartha Maria Knoppers
McGill University
Co-authored papers
10
Edward C Oldfield
Co-authored papers
3
Erika Kleiderman
Universite de Montreal.
Co-authored papers
3
Kym M Boycott
Children's Hospital of Eastern Ontario
Co-authored papers
2
Ma'n H Zawati
McGill University
Co-authored papers
2
Vardit Ravitsky (CM4AI)
The Hastings Center
Co-authored papers
2
Boris Ma??ek
Interfaculty Institute for Cell Biology, University of Tubingen
Co-authored papers
1
Insoo Hyun
Center for Bioethics, Harvard Medical School
Co-authored papers
1
Andrea Jurisicova
Lunenfeld-Tanenbaum Research Institute
Co-authored papers
1
Amy Zarzeczny
University of Regina
Co-authored papers
1
Yann Joly
McGill University.
Co-authored papers
1
Steven J M Jones
University of British Columbia
Co-authored papers
1
Christian R Marshall
Co-authored papers
1
Patrick Bedford
Manager of Clinical Translation and Regulatory Affairs
Co-authored papers
1
Yasmeen Jaafar
University of Alberta
Co-authored papers
1
Stanislav Birko
UNIVERSITY OF MONTREAL
Co-authored papers
1
Adrian Thorogood
Terry Fox Research Institute.
Co-authored papers
1
Jenny Du
University of Alberta
Co-authored papers
1
Chandree L Beaulieu
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa
Co-authored papers
1
Michael Brudno
University of Toronto
Co-authored papers
1
Stephen W Scherer
The Hospital for Sick Children
Co-authored papers
1
Karine Sénécal
Co-authored papers
1
Yonida Koukio
York University
Co-authored papers
1
Ubaka Ogbogu
University of Alberta
Co-authored papers
1
Zubin Master
Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic
Co-authored papers
1
Arthur Leader
University of Ottawa Faculty of Medicine
Co-authored papers
1
Maeghan Toews
University of Adelaide
Co-authored papers
1
Anne-Marie Laberge
UNIVERSITY OF MONTREAL
Co-authored papers
1
Fran??ois Rousseau
Universite Laval
Co-authored papers
1
Forough Noohi
The University of Chicago
Co-authored papers
1
1 - 30